Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

The Binding Site Group

US

Last updated May 24, 2026

Part of The Binding Site Group Ltd

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (283)

Page 2 of 6
DeviceModel / ReferenceRegistriesClassStatus
Human Haptoglobin Kit for use on SPAPLUS NK058.S
FDA UDI
Class IIUnknown
Optilite C1 Inactivator Kit NK019.OPT.A
FDA UDI
Class IIActive
Optilite Freelite Mx Kappa Free Kit LK016.M.OPT.A
FDA UDI
Class IIActive
Optilite® Low Level Albumin Control Pack NQ032.L.OPT
FDA UDI
Class IActive
Human IgG, IgA, IgM ‘NL’ BINDARID™ COMBI RID Kit RK002
FDA UDI
Class IIUnknown
Human IgG1 Subclass Liquid Reagent Kit for use on the SPAPLUS –Bulk Kit NK006.10S
FDA UDI
N/AActive
Human IgG Control Pack for use on the SPAPLUS® NQ004.S
FDA UDI
Class IActive
Human Complement C4 ‘NL’ BINDARID™ Radial Immunodiffusion Kit RN025.3
FDA UDI
Class IIActive
Human C4 Kit for use on SPAPLUS NK025.S
FDA UDI
Class IIUnknown
VaccZyme™ Human Anti-Haemophilus Influenzae type b Enzyme Immunoassay Kit MK016
FDA UDI
Class IIActive
Optilite CH50 Calibrator NC095.OPT.A
FDA UDI
Class IIActive
Human alpha 1 antitrypsin Kit for use on SPAPLUS NK034.S
FDA UDI
Class IIUnknown
Human IgG3 Subclass Liquid Reagent Kit for use on Hitachi 911/912/917, Modular P LK008.H
FDA UDI
Class IIActive
Hevylite® Human IgA Kappa Kit for use on the SPAPLUS NK623.S.A
FDA UDI
Class IIActive
Tetanus Toxoid IgG Calibrator Set EA115.A
FDA UDI
Class IActive
MININEPH™ Human Prealbumin Kit ZK066.R
FDA UDI
N/AUnknown
Optilite® IgG3 Kit (x10) LK008.10.OPT.A
FDA UDI
Class IIActive
Freelite® Human Lambda Free Control Pack for use on the SPAPLUS® NQ018.S
FDA UDI
Class IUnknown
Human IgG3 Subclass Liquid Reagent Kit for use on the Siemens BNII Analyser NK008.T
FDA UDI
Class IIUnknown
Human IgG3 Subclass Liquid Reagent Kit for use on the SPAPLUS- Bulk Kit LK008.10S
FDA UDI
N/AActive
Freelite® Human Lambda Free Kit for use on the Hitachi 911/912/917/Modular P LK018.H
FDA UDI
Class IIActive
Human CH50 controls for use on SPAPLUS NQ095.S
FDA UDI
Class IUnknown
Hu IgG4 Subclass Liquid Reagent Kit for use on Hitachi 911/912/917 and Modular P LK009.H
FDA UDI
N/AActive
Human IgM - ‘NL’ BINDARID™ Radial Immunodiffusion Kit RN012.3
FDA UDI
Class IIUnknown
MININEPH™ Human Rheumatoid Factor Kit ZK151.L.R
FDA UDI
N/AUnknown
Freelite® Human Lambda Free Control Pack For use on the Roche Cobas Integra® NQ018.RI
FDA UDI
Class IUnknown
Human Albumin CSF Kit for use on SPAPLUS NK032.L.S
FDA UDI
Class IIActive
Human Beta-2 Microglobulin Urine Kit for use on the SPAPLUS LK043.U.S
FDA UDI
Class IIActive
Freelite® Panel Sample Set BP228
FDA UDI
Class IActive
Human Cystatin C Control Pack for use on the SPAPLUS® NQ048.S
FDA UDI
Class IUnknown
Optilite Low Level Albumin Kit NK032.L.OPT.A
FDA UDI
Class IIActive
Human IgG Subclass Liquid Reagent Kit for use on the Siemens BN™II LK001.TB
FDA UDI
Class IIUnknown
Immunofixation (IFE) Kit XK001
FDA UDI
Class IIUnknown
Total Haemolytic Complement RC001.2
FDA UDI
Class IIActive
IgD AMR Fluid BP506
FDA UDI
Class IActive
Human C1 Inactivator BINDARID™ Radial Immunodiffusion Kit RN019.3
FDA UDI
Class IIActive
Optilite® Low Level Total Protein Reagent NK061.L.OPT.A
FDA UDI
Class IActive
Hevylite® Human IgM Lambda Kit for use on the SPAPLUS NK626.S.A
FDA UDI
Class IIActive
Optilite IgM Kit NK012.OPT.A
FDA UDI
Class IIActive
Human Immunoglobulin D BINDARID™ Radial Immunodiffusion Kit RN013.3
FDA UDI
Class IIActive
Minifix™ Kit XK004
FDA UDI
N/AUnknown
Optilite Hevylite® IgM Lambda Kit NK626.OPT.A
FDA UDI
Class IIActive
Human IgG4 Subclass Liquid Reagent Kit for use on the Beckman Coulter AU® series LK009.AU
FDA UDI
Class IIActive
Optilite IgG4 Kit LK009.OPT.A
FDA UDI
Class IIActive
Human IgG1 Subclass Liquid Reagent Kit for use on the Siemens BN™II NK006.TB
FDA UDI
Class IIActive
Freelite® Lambda AMR Check Fluid SD BP539.SD
FDA UDI
Class IActive
Sheep Anti-Human Kappa Free Light Chains Immunofixation Grade PX016
FDA UDI
Class IIUnknown
Human IgG Liquid Reagent Kit for use on the SPAPLUS –Bulk Kit NK004.10S.A
FDA UDI
Class IIActive
Human C3c Control Pack for use on the SPAPLUS® NQ023.S
FDA UDI
Class IUnknown
Lipoprotein (a) Kit for use on SPAPLUS LK098.S
FDA UDI
Class IIUnknown

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (28)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Oct 15, 2021Z-0274-2022—terminated

Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer.

May 20, 2021Z-2030-2021—terminated

The high and low level "Quality Controls" demonstrate a positive bias of approximately 10% compared to assigned values.

Nov 18, 2020Z-0943-2021—terminated

Due to customer complaints of positive bias impacting quality control. The high and low level controls are demonstrating a positive bias compared to assigned values.

Apr 9, 2020Z-2071-2020—terminated

A software issue that may affect the analyzer's result accuracy.

Nov 6, 2019Z-1500-2020—terminated

It has been identified that the rheumatoid factor (RF) calibrator values over recover in comparison to the reference material RF serum. This could result in reporting falsely abnormal results which may lead to unnecessary additional serological testing.

Oct 7, 2019Z-2110-2020—terminated

Assigned Rheumatoid Factor (RF) calibrator value for calibrator component included in kit used to aid in the diagnosis of rheumatoid arthritis over recovers by 7% in comparison to the reference material RF serum. This could result in reporting abnormal (false positive) results, which may lead to unnecessary additional serological testing and a delay in treatment.

Jul 29, 2019Z-1327-2020—terminated

There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.

Apr 25, 2019Z-1619-2020—terminated

A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected

Feb 19, 2019Z-0671-2020—terminated

Deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits

Nov 6, 2018Z-0604-2019—terminated

Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.

Aug 12, 2018Z-1469-2020—terminated

A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.

Jul 25, 2018Z-0477-2019—terminated

After running the calibration curve, the recovery of the IgM kit control results decrease demonstrating a reduction in accuracy within the same day; control results may be out of range one day after running the assay calibration curve. Samples have been shown to be similarly affected.

Mar 9, 2018Z-1301-2018—terminated

The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.

Jan 4, 2018Z-0553-2018—terminated

The low and high controls for the product are returning results above the assigned values.

Aug 23, 2017Z-0002-2018—terminated

The high control for the kit is recovering low and may be out of range for assigned values.

Dec 23, 2016Z-1089-2017—terminated

A change to the lower end of the measuring range and product insert did not reflect the change.The measuring range provided in instrument parameters is correct but contradicts the information provided in the product insert

Oct 28, 2016Z-1053-2017—terminated

A change in the calibration curve causing an increase in false prozone flags.

Jul 5, 2016Z-1043-2017—terminated

Batch numbers listed are reporting Lambda Free Light Chain results >114mg/L that are on average 33% lower than other Optilite Lambda Freelite batches. Therefore users moving to this batch will see results >114mg/L giving lower results and conversely when switching to the next batch results will be seen to shift upwards.

May 13, 2015Z-1018-2017—terminated

Potential risk of the Optilite lid/cover falling suddenly and causing injury when not placed in the fully open position.

Sep 11, 2014Z-1068-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1071-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1073-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1072-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1067-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1070-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1069-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Nov 28, 2012Z-1050-2017—terminated

Calibration curve activity has increased over time in the kit lots listed.

Oct 9, 2012Z-1055-2017—terminated

If a control ring is marked after reading, the software will not flag results that are out of the specified QC range.